"compound 1"
avb6 integrin inhibitor + lysosomal degrader in vitro degradation, Ph. I completed, discont. derived from prior integrin inhibitors J. Pharmacol. Exp. Ther., Jan. 26, 2021 GlaxoSmithKline, Stevenage, UK
Molecules of the Month - January 2021
Molecules of the Month
- remogliflozin etabonate
- GLPG2451
- BI 730357
- MLi-2
- "compound 1"
- "compound 5i"
- E7386
- NVS-BET-1
- "compound 16"
- JNJ-63576253 / TRC-253
- dosimertinib
- BMS-986242
- CCS1477
- Con B-1